Sino-Pharma-B Files Lawsuit Against Former Executives Over $20M Investment on August 14
According to Sino-Pharma-B (02257), on August 14, 2026, the company and its wholly-owned subsidiary Sino-Pharma (Hong Kong) Limited filed a writ of summons with Hong Kong High Court (Case No. HCA1427/2026) against former executives Dr. Lu Yang, Dr. Dai Xiaochuang, and Mr. Ye Yongjie. The lawsuit
SIRNAOMICS-B-3.55%
GateNews·08-14 13:11
